Literature DB >> 558343

Biophysical studies of infectious pancreatic necrosis virus.

P Dobos, R Hallett, D T Kells, O Sorensen, D Rowe.   

Abstract

The molecular weight of infectious pancreatic necrosis virus (IPNV) has been determined by analytical ultracentrifugation and dynamic light scattering. The sedimentation coefficient of the virus was found to be 435S. The average value for molecular weight is (55 +/- 7) x 106. The virus genome consists of two segments of double-stranded RNA (molecular weights, 2.5 x 106 and 2.3 x 106), which represents 8.7% of the virion mass. The capsid protein moiety of IPNV consists of four species of polypeptides, as determined by polyacrylamide gel electrophoresis. The number of molecules of each polypeptide in the virion has been determined. There are 22 molecules of the internal polypeptide alpha (molecular weight, 90,000), 544 molecules of the outer capsid polypeptide beta (molecular weight, 57,000), and 550 and 122 molecules, respectively, of the internal polypeptides gamma1 (molecular weight, 29,000) and gamma2 (molecular weight, 27,000). IPNV top component contains only the beta polypeptide species, and its molecular weight is estimated to be 31 x 106. The hydrodynamic diameter and electron microscopic diameter (calculated by catalase crystal-calibrated electron microscopy) of IPNV was compared with those of reovirus and encephalomyocarditis virus. Due to the swelling of the outer capsid, reovirus particles were found to be much larger when hydrated (96-nm diameter) than when dehydrated (76-nm diameter), having a large water content content and low average density. In contrast, IPNV particles are more rigid, having nearly the same average diameter under hydrous (64 nm) as under anhydrous conditions (59.3 nm). Encephalomyocarditis virus has a very low water content and does not shrink at all when prepared for electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 558343      PMCID: PMC515695     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  THE SECONDARY STRUCTURE OF REOVIRUS RNA.

Authors:  P J Gomatos; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

2.  Size and structure of the genome of infectious pancreatic necrosis virus.

Authors:  P Dobos
Journal:  Nucleic Acids Res       Date:  1976-08       Impact factor: 16.971

3.  Molecular weights of vesicular stomatitis virus and its defective particles by laser light-scattering spectroscopy.

Authors:  B R Ware; T Raj; W H Flygare; J A Lesnaw; M E Reichmann
Journal:  J Virol       Date:  1973-01       Impact factor: 5.103

4.  Virus-specific polypeptides in ascites cells infected with encephalomyocarditis virus.

Authors:  P Dobos; E M Martin
Journal:  J Gen Virol       Date:  1972-11       Impact factor: 3.891

5.  Simple method for the isolation of encephalomyocarditis virus ribonucleic acid.

Authors:  I M Kerr; E M Martin
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

6.  Polypeptide components of virions, top component and cores of reovirus type 3.

Authors:  R E Smith; H J Zweerink; W K Joklik
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

7.  Physico-chemical and morphological features of infectious pancreatic necrosis virus.

Authors:  J Cohen; A Poinsard; R Scherrer
Journal:  J Gen Virol       Date:  1973-12       Impact factor: 3.891

8.  Electron microscopical and biochemical characterization of infectious pancreatic necrosis virus.

Authors:  R K Kelly; P C Loh
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

9.  Biophysical studies of reovirus type 3.

Authors:  J A Farrell; J D Harvey; A R Bellamy
Journal:  Virology       Date:  1974-11       Impact factor: 3.616

10.  Virus-specific protein synthesis in cells infected by infectious pancreatic necrosis virus.

Authors:  P Dobos
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  18 in total

1.  Peptide map comparison of the proteins of infectious bursal disease virus.

Authors:  P Dobos
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

2.  Genome assembly and particle maturation of the birnavirus infectious pancreatic necrosis virus.

Authors:  Rodrigo A Villanueva; José L Galaz; Juan A Valdés; Matilde M Jashés; Ana María Sandino
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Attachment and entry of infectious pancreatic necrosis virus (IPNV) into CHSE-214 cells.

Authors:  J Kuznar; M Soler; G Farias; J C Espinoza
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Poikilotherm vertebrate cell lines and viruses: a current listing for fishes.

Authors:  K Wolf; J A Mann
Journal:  In Vitro       Date:  1980-02

5.  Evidence that infectious pancreatic necrosis virus has a genome-linked protein.

Authors:  R H Persson; R D Macdonald
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

6.  Virus-specific RNA synthesis in cells infected by infectious pancreatic necrosis virus.

Authors:  P Somogyi; P Dobos
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

7.  Infectious pancreatic necrosis virus: identification of a VP3-containing ribonucleoprotein core structure and evidence for O-linked glycosylation of the capsid protein VP2.

Authors:  A Hjalmarsson; E Carlemalm; E Everitt
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Isolation and characterization of infectious pancreatic necrosis virus from pike (Esox lucius).

Authors:  W Ahne
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

9.  Characterization of a new serotype of infectious pancreatic necrosis virus isolated from Atlantic salmon.

Authors:  K E Christie; L S Håvarstein; H O Djupvik; S Ness; C Endresen
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

10.  Peptide map comparison of infectious pancreatic necrosis virus-specific polypeptides.

Authors:  P Dobos; D Rowe
Journal:  J Virol       Date:  1977-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.